Rosen Quoted on Prescription Drug Industry

Partner David Rosen was quoted in a Washington Post article, “Regulators Take a Growing Interest in Drugmakers’ Moves to Protect Profits,” on March 19, 2015. The article discussed the competitive nature of patents for the prescription drug market, along with related antitrust issues. Rosen was quoted saying, “This industry is under a lot of scrutiny because the cost savings in the generic world are pretty high for the public.”